MiNK Therapeutics Future Growth
Future criteria checks 0/6
MiNK Therapeutics is forecast to grow earnings and revenue by 30.5% and 64% per annum respectively while EPS is expected to grow by 29.8% per annum.
Key information
30.5%
Earnings growth rate
29.8%
EPS growth rate
| Biotechs earnings growth | 21.3% |
| Revenue growth rate | 64.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 21 Mar 2024 |
Recent future growth updates
Recent updates
MiNK Therapeutics (NASDAQ:INKT) Will Have To Spend Its Cash Wisely
Oct 26
Is MiNK Therapeutics (NASDAQ:INKT) In A Good Position To Deliver On Growth Plans?
Jun 28Is MiNK Therapeutics (NASDAQ:INKT) In A Good Position To Invest In Growth?
Mar 18MiNK Therapeutics GAAP EPS of -$0.18
Aug 16MiNK Therapeutics GAAP EPS of -$0.18
Aug 09MiNK Therapeutics A Bargain For Potential Cell Therapies
Jun 23We're Hopeful That MiNK Therapeutics (NASDAQ:INKT) Will Use Its Cash Wisely
May 05Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4 | -40 | -51 | N/A | 3 |
| 12/31/2025 | N/A | -36 | -45 | N/A | 4 |
| 12/31/2024 | N/A | -19 | -25 | N/A | 4 |
| 12/31/2023 | N/A | -22 | -16 | -16 | N/A |
| 9/30/2023 | N/A | -25 | -17 | -17 | N/A |
| 6/30/2023 | N/A | -26 | -19 | -19 | N/A |
| 3/31/2023 | N/A | -26 | -19 | -19 | N/A |
| 12/31/2022 | N/A | -28 | -19 | -19 | N/A |
| 9/30/2022 | N/A | -26 | -16 | -16 | N/A |
| 6/30/2022 | N/A | -34 | -14 | -14 | N/A |
| 3/31/2022 | N/A | -34 | -13 | -13 | N/A |
| 12/31/2021 | N/A | -30 | -13 | -13 | N/A |
| 9/30/2021 | N/A | -26 | -13 | -13 | N/A |
| 6/30/2021 | N/A | -18 | -12 | -12 | N/A |
| 3/31/2021 | N/A | -16 | -11 | -11 | N/A |
| 12/31/2020 | N/A | -16 | -8 | -8 | N/A |
| 12/31/2019 | 1 | -24 | -15 | -15 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: INKT is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: INKT is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: INKT is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: INKT is forecast to have no revenue next year.
High Growth Revenue: INKT is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if INKT's Return on Equity is forecast to be high in 3 years time